专职PI
李大强 研究员
研究员,博士生导师
E-mail: daqiangli1974@fudan.edu.cn
 

  1998年7月及2003年7月在重庆医科大学分别获得医学学士学位及医学博士学位。2003年8月至2009年10月先后在复旦大学附属肿瘤医院、美国凯斯西储大学 (Case Western Reserve University)、德州大学安德森肿瘤中心 (University of Texas M.D. Anderson Cancer Center) 及乔治华盛顿大学 (George Washington University) 从事博士后研究工作。2009年11月起任乔治华盛顿大学生物化学及分子生物学系Faculty 及Assistant Research Professor,并于2013年7月升职为Associate Research Professor。2013年9月回国任复旦大学生物医学研究院及肿瘤研究所双聘PI,研究员,入选2013年上海高校特聘教授(东方学者)。
  一直从事肿瘤侵袭转移及治疗耐药的分子机制研究,在Cancer Cell、Mol Cell、Cell Rep、Hepatology、J Cell Biol、Nat Commun以及Proc Natl Acad Sci U S A等国际期刊上发表SCI论文39篇,其中第一或共同第一作者16篇,通讯/共同通讯作者9篇。所发表论文被Nature、Nat Rev Mol Cell Biol权威期刊进行了报道, 被Cell、Nat Rev Cancer、Nat Rev Mol Cell Biol、Nat Rev Drug Discov、Nat Med、Physiol Rev 等权威刊物引用。目前担任国际权威杂志Cancer Research等杂志编委以及Cancer Research等多个杂志的审稿人。


研究领域:

  肿瘤侵袭转移及治疗耐药的分子机制


研究团队:



代表性论著:(#为共同第一作者; *为共同通讯作者)

  1. Li DQ#, Pakala SB#, Reddy SD, Peng S, Balasenthil S, Deng CX, Lee CC, Rea MA, Kumar R. Metastasis-associated protein 1 is an integral component of the circadian molecular machinery. Nat Commun, 2013; 4:2545. 
  2. Li DQ*, Nair SS, Ohshiro K, Kumar A, Nair VS, Pakala SB, Reddy SD, Gajula RP, Eswaran J, Aravind L, Kumar R*. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep, 2012; 2:1657–1669.
  3. Li DQ, Pakala SB, Reddy SD, Ohshiro K, Zhang JX, Wang L, Zhang Y, de Alborán IM, Pillai MR, Eswaran J, Kumar R. Bidirectional autoregulatory mechanism of metastasis  associated protein 1-alternative reading frame pathway in oncogenesis. Proc Natl Acad Sci U S A, 2011; 108: 8791-8796.
  4. Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, Rayala SK, Kumar R. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci U S A, 2009; 106: 17493-17498.
  5. Li DQ, Pakala SB, Nair SS, Eswaran J, Kumar R. Metastasis-associated protein 1 /nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res, 2012; 72: 387-394.
  6. Zhang JX#, Li DQ#,*, He AR, Motwani M, Vasiliou V, Eswaran J, Mishra L, Kumar R. Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases. Hepatology, 2012; 55: 1840-1851. 
  7. Molli PR#, Li DQ#, Bagheri-Yarmand R, Pakala SB, Katayama H, Sen S, Iyer J, Chernoff J, Tsai MY, Nair SS, Kumar R. Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. J Cell Biol, 2010; 190:101-114. (评论见Nat Rev Mol Cell Biol, 2010; 11: 542)
  8. Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, Basilion JP, Sedor J, Wu J, Danielpour D, Sloan AE, Cohen ML, Wang B. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell, 2009; 16: 9-20. (评论见Nature, 2009; 461:149)
  9. Nair SS, Li DQ, Kumar R. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Mol Cell, 2013; 49(4):704-18.
  10. Li DQ, Ohshiro K, Khan MN, Kumar R. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function. J Biol Chem, 2010; 285(26):19802-12.
  11. Li DQ#, Pakala SB#, Reddy SD, Ohshiro K, Peng SH, Lian Y, Fu SW, Kumar R. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem, 2010; 285(13): 10044-52.
  12. Li DQ, Divijendra Natha Reddy S, Pakala SB, Wu X, Zhang Y, Rayala SK, Kumar R. MTA1 coregulator regulates p53 stability and function. J Biol Chem, 2009; 284(50): 34545-52.
  13. Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer, 2006; 42(18):3274-86.
  14. Li DQ, Wang L, Fei F, Hou YF, Luo JM; Wei-Chen, Zeng R, Wu J, Lu JS, Di GH, Ou ZL, Xia QC, Shen ZZ, Shao ZM. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics, 2006; 6(11): 3352-68.
  15. Li DQ*, Kumar R*. Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer. Adv Cancer Res, 2015;127: 1-47.
  16. Li DQ*, Yang Y, Kumar R*. MTA family of proteins in DNA damage response: mechanistic insights and potential applications. Cancer Metastasis Rev, 2014; 33(4): 993-1000.
  17. Li DQ, Nair SS, Kumar R. The MORC family: new epigenetic regulators of transcription and DNA damage response. Epigenetics, 2013; 8(7): 685-93.
  18. Li DQ, Kumar R. Mi-2/NuRD complex making inroads into DNA-damage response pathway. Cell Cycle, 2010; 9(11): 2071-9.
  19. Kumar R*, Li DQ*. PAKs in Human Cancer Progression: From Inception to Cancer Therapeutic to Future Oncobiology. Adv Cancer Res, 2016;130:137-209.
  20. Zhang Y, Yang YL, Zhang FL, Liao XH, Shao ZM*, Li DQ*. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4. Cancer Med, 2018; 7(4): 1317-1325.
  21. Liao XH, Zhang Y, Dong WJ, Shao ZM*, Li DQ*. Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1. Oncotarget, 2017; 8(58): 97941-97954.
  22. Zhang Y, Liao XH, Xie HY, Shao ZM*, Li DQ*. RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells. Oncotarget, 2017; 8(55): 94505-94518.
  23. Xie HY, Shao ZM*, Li DQ*. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis. Chin J Cancer, 2017; 36(1):36.
 
复旦大学肿瘤研究所 通讯地址: 东安路270号2号楼1312室 64175590-5312 Email:fuci2012@126.com
Copyright 2013 shca.org.cn All rights reserved. 复旦大学肿瘤研究所 版权所有